GEN 4001
Economics of Biotechnology
Stanford University · UGRD · Fall 2026
1 section
Catalog description
Focuses on translation of promising research discovery into marketed drugs and the integration of scientific method, clinical needs assessment, clinical and regulatory strategy, market analysis, economic considerations, and the influence of the healthcare economic ecosystem necessary for successful translation. Explores the economic perspectives of various stakeholders--patients, providers, payers, biotechnology and pharmaceutical companies, FDA, and financial markets--and how they influence drug development.
Sections
Current meeting, instructor, credit, and enrollment details
001
Availability not recently verifiedClass #stanford-4001Fall 2026UGRD2 credits
- Days & times
- No scheduled meeting time
- Meeting dates
- —
- Location
- —
- Instructor
- Staff
Class numbers and section codes come from the registrar.
Spot missing or incorrect course data?